AmBisome liposomal

Medicinal product

(Invented) name

AmBisome liposomal

Active substance (s)

Amfotericinas B

Strength

50 mg

Pharmaceutical form

milteliai infuzinės dispersijos koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J02AA01, Amphotericin B

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-11-28

Date of renewal

Documents

3036_AMBISOME liposomal 50 mg_N1 N10_PL.docx

3036_AMBISOME liposomal 50 mg_N1 N10_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Flakone yra	1 vnt.
Amfotericinas B	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119263	105367	1105367	flakonas	N1 (+5 mikronų filtras)		Receptinis	LT/L/25/3036/001	Netiekiama	-	-	No	-	-	Download
119264	105368	1105368	flakonas	N10 (+5 mikronų filtras)		Receptinis	LT/L/25/3036/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-11-28	Registruotas